SEC Filing Summary: BioSig Technologies, Inc. (BSGM)
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. on April 22, 2020, covering events occurring on April 21, 2020. The registrant is a Delaware corporation headquartered in Westport, Connecticut, with common stock trading on the NASDAQ Capital Market under the symbol BSGM.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
The primary material event reported is a corporate governance change. On April 21, 2020, BioSig Technologies, Inc. announced the appointment of Anthony Zook to the board of directors of its majority-owned subsidiary, ViralClear Pharmaceuticals, Inc.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for financial guidance, future outlook, management commentary on operations, specific risks, contingencies, or unusual items beyond the board appointment.
Key Facts for Investor Verification
- Anthony Zook has been appointed to the board of ViralClear Pharmaceuticals, Inc., a majority-owned subsidiary.
- The press release detailing this appointment is filed as Exhibit 99.1.
- The report was signed by Kenneth L. Londoner, Executive Chairman.
- No financial data or operational metrics are included in this specific filing.